Unfractionated heparin: Difference between revisions
ClaireLewis (talk | contribs) |
|||
(24 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
== | ==General== | ||
* | *Type: [[Anticoagulant]] | ||
* | *Dosage Forms: IV, SC | ||
* | *Common Trade Names: Heparin | ||
* | |||
* | ==Adult Dosing== | ||
** | *See [https://depts.washington.edu/anticoag/home/content/heparin-infusion-guidelines University of Washington pharmacy heparin infusion guidelines] | ||
*33% of | ===Thromboembolism=== | ||
*Bolus: 80 units/kg IV x 1 (MAX: 5,000 units) | |||
*Then drip: 18 units/kg/h IV (MAX: 1,000 units/h) | |||
*Adjust dose to target aPTT levels based on nomogram | |||
==Pediatric Dosing== | |||
*IV infusion | |||
**Initial loading dose 75 units/kg given over 10 minutes | |||
**Initial maintenance dose 20 units/kg/hour and adjest per local policy | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | |||
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal | |||
*Renal Dosing | |||
**No adjustment | |||
*Hepatic Dosing | |||
**No adjustment | |||
==Contraindications== | |||
*Allergy to class/drug | |||
*33% of patients develop some form of bleeding complication; 2-6% develop major bleeding | |||
*Heparin-Induced Thrombocytopenia | |||
*See [[HIT (Heparin-Induced Thrombocytopenia)]] | |||
===Risk Factors for Major Bleeding Complication=== | ===Risk Factors for Major Bleeding Complication=== | ||
*Recent surgery or trauma | |||
*Renal failure | |||
*Alcoholism | |||
*Malignancy | |||
*Liver failure | |||
*Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs | |||
== | ==Pharmacology== | ||
*Half-life: 1.5 hrs | |||
*Metabolism: Hepatic | |||
*Excretion: Urine | |||
*Mechanism of Action: | |||
**Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin | |||
*Anticoagulation effect lasts up to 3hr after stopping infusion | |||
*Must give IV (not subq) for acute thromboembolic disease | |||
**Unpredictable anticoagulation effect | |||
**Must monitor with PTT; therapeutic range is 1.5-2.5x normal value | |||
==See Also== | ==See Also== | ||
*[[Low | *[[Unfractionated heparin reversal]] | ||
*[[Coagulopathy (main)]] | |||
*[[Low molecular weight heparin]] | |||
== | ==References== | ||
<references/> | |||
[[Category: | [[Category:Pharmacology]] |
Revision as of 17:25, 19 September 2019
General
- Type: Anticoagulant
- Dosage Forms: IV, SC
- Common Trade Names: Heparin
Adult Dosing
Thromboembolism
- Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
- Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
- Adjust dose to target aPTT levels based on nomogram
Pediatric Dosing
- IV infusion
- Initial loading dose 75 units/kg given over 10 minutes
- Initial maintenance dose 20 units/kg/hour and adjest per local policy
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk minimal
- Renal Dosing
- No adjustment
- Hepatic Dosing
- No adjustment
Contraindications
- Allergy to class/drug
- 33% of patients develop some form of bleeding complication; 2-6% develop major bleeding
- Heparin-Induced Thrombocytopenia
- See HIT (Heparin-Induced Thrombocytopenia)
Risk Factors for Major Bleeding Complication
- Recent surgery or trauma
- Renal failure
- Alcoholism
- Malignancy
- Liver failure
- Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
Pharmacology
- Half-life: 1.5 hrs
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action:
- Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
- Anticoagulation effect lasts up to 3hr after stopping infusion
- Must give IV (not subq) for acute thromboembolic disease
- Unpredictable anticoagulation effect
- Must monitor with PTT; therapeutic range is 1.5-2.5x normal value